The Global Health
Innovative Technology Fund (GHIT Fund) is a non-profit organisation focused on
promoting the discovery and development of new health technologies, including drugs,
vaccines, and diagnostics for infectious diseases prevalent in
developing countries. The GHIT Fund aims to advance Japan’s wealth of health
technology innovation for the discovery and development of new technologies for
developing world patients and populations affected by infectious disease. To
this end, the GHIT Fund will catalyse R&D partnerships between Japanese and
non-Japanese organisations and support these partnerships through GHIT Fund
investments.
Interested applicants must complete the Intent to Apply form (available
at https://www.ghitfund.org/afag/grant/en)
and submit this to the GHIT Fund via Editorial Manager® no later than 10:00am (Tokyo time) on 28 July 2016.
When submitting your Intent to Apply form on the Editorial Manager®,
please list all the collaboration partners participating in the project; the
name and details (including email address) of at least one representative from
each organisation must be indicated.
Applicants who successfully submit the Intent to Apply document will
receive a confirmation email. GHIT Fund staff will then perform an initial
partnership and scope eligibility assessment. Only eligible applicants will
be invited to submit the full proposal and will receive the proposal templates
from the GHIT Fund.
Further information about the scheme is available at https://www.ghitfund.org/assets/attach/GHIT-RFP-PD-2016-002.pdf
No comments:
Post a Comment